News
Pharmacy & healthcare news
Industry updates, regulation, and developments that matter to Indian pharmacies.
Dabur to remove ‘anti-inflammatory’, ‘anti-bacterial’, ‘analgesic’ claims from toothpaste labels after FDA order
Dabur India Ltd has assured the Bombay High Court that it will drop certain therapeutic claims from the labels of its toothpastes, as per the directions of the Maharashtra FDA.
Mar 29, 2025
Seven Booked in Mumbai for Illegal Import and Sale of Medicines Without Bills
Bandra Police have registered a Zero FIR against seven individuals for allegedly importing and selling high-value medicines illegally without receipts.
Mar 29, 2025
IPC Flags Serious Adverse Reactions Linked to 5 Common Drugs
The Indian Pharmacopoeia Commission (IPC) recently released a March 2025 drug safety warning regarding adverse reactions associated with five popular drugs, namely Metronidazole, Luliconazole, Dalteparin, Gliclazide, and Tramadol.
Mar 28, 2025
IIT Roorkee discovers thymol-based approach to tackle antibiotic-resistant infections
Researchers at IIT Roorkee have identified thymol—a natural plant-based compound—as a promising weapon against persistent bacterial infections, especially those caused by drug-resistant Acinetobacter baumannii.
Mar 27, 2025
India Should Abolish QR Code System and Implement Unbreachable Anti-Counterfeiting System
Global counterfeiting specialist Dr. Avi Chaudhuri has asked the Indian government to instantly cancel the current QR code-based verification process for drugs, stating it is now a counterfeiters' ally rather than a consumer safety measure.
Mar 27, 2025
US FDA Approves First-Ever Treatment for Prader-Willi Syndrome
It is a rare disease treatment milestone that the US FDA has approved Soleno Therapeutics' medication Vykat XR as the first-ever approved treatment for Prader-Willi syndrome (PWS).
Mar 27, 2025
Eli Lilly Open to Indian Partnerships for Mounjaro Distribution, Says CEO David Ricks
Following the recent launch of its blockbuster anti-diabetes and weight-loss drug Mounjaro in India, pharma major Eli Lilly has expressed openness to partnering with Indian companies to expand distribution and market reach.
Mar 26, 2025
Government Approves Price Increase of Cancer, Diabetes, and Cardiac Medicines in India
Prices of essential, government-controlled medicines in India — such as life-saving cancer, diabetes, and cardiac drugs — will go up by 1.7%, official sources say.
Mar 26, 2025
Pharmacy owner and three others arrested in Trichy for illegal sale of Tapentadol
Trichy city police have busted a drug racket involving the illegal sale of Tapentadol, a prescription-only narcotic painkiller, to local youth for recreational use.
Mar 26, 2025
Father and son arrested in Himachal for illegal drug sale worth ₹1.88 lakh
In a major crackdown on unauthorised drug trafficking, the Health Department and district police in Himachal Pradesh apprehended a man and his son for illegally selling narcotics and unlicensed medicines in Salooni tehsil of Chamba district.
Mar 25, 2025
India Urged to Build National Pharmacy Movement to Achieve Viksit Pharmacy@2030 Vision
Dr. Premnath Shenoy, former president of the IPA Karnataka branch and current quality and compliance advisor, has called for the launch of a nationwide pharmacy movement to achieve the vision of Viksit Pharmacy@2030, mirroring the broader national development vision of Viksit Bharat@2047.
Mar 25, 2025
TB in India remains a major public health challenge linked to pollution malnutrition and stigma
Even with sustained medical advancements and government initiatives to eliminate TB, tuberculosis continues to be among India's top killers.
Mar 25, 2025
AI-Driven Device by PGI Set to Transform Neuropathic Pain Diagnosis in India
Postgraduate Institute of Medical Education and Research (PGI), Chandigarh, has developed an innovative AI-powered device to diagnose neuropathic pain conditions such as diabetic neuropathy and sciatica.
Mar 24, 2025
BPaLM Regimen Offers New Hope for MDR-TB Treatment but Faces Implementation Challenges
The BPaLM regimen—Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin—is a game-changer in the treatment of multidrug-resistant tuberculosis (MDR-TB) in India.
Mar 24, 2025
Gujarat FDCA Puts Down Illicit Sale of Narcotic and Psychotropic Substances
The Gujarat Food & Drugs Control Administration (FDCA) has strengthened its drive against the unauthorized sale and distribution of narcotic and psychotropic drugs, focusing on chemicals such as codeine syrup, alprazolam, tramadol, and nitrazepam. Its Commissioner, Dr. H G Koshia, is leading the department in actively carrying out inspections, monitoring pharmacies, and imposing stringent legal measures to dissuade drug abuse and protect public health.
Mar 24, 2025
Pharmacist-Led Innovations Could Revolutionize Hypertension Care in Underserved Communities
Pharmacist-driven interventions are showing promise in addressing the growing burden of hypertension, especially among underserved populations.
Mar 24, 2025
AI Model Accurately Estimates Biological Age Using 5 Drops of Blood, Reveals Impact of Stress on Aging
Researchers at Osaka University have developed an innovative AI-driven model that can estimate a person’s biological age using just five drops of blood.
Mar 23, 2025
Andhra Police Register 125 Cases in Statewide Crackdown on Illegal Stocking of Narcotic Drugs
The Andhra Pradesh police, along with Vigilance and Enforcement teams and the Drug Control Administration (DCA), have intensified their raids on medical stores across the state.
Mar 22, 2025
Eli Lilly Launches Mounjaro Weight Loss Drug in India
US pharma giant Eli Lilly & Co. has launched its much-anticipated anti-obesity drug, Mounjaro (tirzepatide), in India. Priced significantly lower than its US counterpart, the drug is India’s first-of-its-kind treatment for obesity, targeting both weight loss and type-2 diabetes management.
Mar 21, 2025
Gujarat HC Stays GST Action Against Gujarat Medical Council and Other Medical Boards
In a major relief to various statutory medical councils in Gujarat, the Gujarat High Court has stayed the Goods & Services Tax (GST) department's proceedings against five regulatory councils and boards over the issue of taxability on the services provided by them.
Mar 21, 2025
USV Launches Xenia Brand Range Following Empagliflozin Patent Expiry
USV Pvt. Ltd. has unveiled its Xenia brand series in India, leveraging the recent patent expiry of Empagliflozin.
Mar 21, 2025
Five Women Experience Delirium After C-Section in Madhya Pradesh Hospital, Anaesthesia Drug Reaction Suspected
Five women aged between 20-25 developed delirium following C-section delivery at Government Gandhi Memorial Hospital in Rewa, Madhya Pradesh. The anaesthesia drug 'Bupivacaine' is suspected to have caused an adverse reaction, and the government has ordered an immediate inquiry into the incident.
Mar 2, 2025
Indian Pharmaceutical Leaders Raise Concerns Over Potential US Tariffs Impacting Drug Prices and Supply
Indian drug industry leaders have complained that potential US tariffs on Indian generic drug exports could result in increased drug prices for American consumers and potential shortages. Industry officials contend that Indian generics account for a big portion of US healthcare cost savings, and the imposition of tariffs would interrupt the supply chain without a hoped-for effect.
Mar 2, 2025
DCA Seizes Spurious Montek-LC Tablets and Unauthorised Medicines in Telangana
The Telangana Drugs Control Administration (DCA) has seized large quantities of spurious Montek-LC tablets and illegally stocked medicines in separate raids conducted across Secunderabad, Sangareddy, and Medchal-Malkajgiri districts.
Mar 19, 2025
Ready to simplify your pharmacy?
Start your free 7-day trial or book a personalised demo today.